Brief: Passage Bio Reports Q1 2023 Financial Results And Provides Recent Business Highlights

Passage Bio

11/05/2023 13:42

May 11 (Reuters) - Passage Bio Inc  PASG.O :
    * PASSAGE BIO REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
AND
PROVIDES RECENT BUSINESS HIGHLIGHTS
    * PASSAGE BIO - ON TRACK TO REPORT INTERIM CLINICAL DATA FOR
2
LEAD PROGRAMS, PBGM01 FOR GM1 GANGLIOSIDOSIS & PBFT02 FOR
FRONTOTEMPORAL DEMENTIA IN 2023
    * PASSAGE BIO INC - EXECUTION SUPPORTED BY STRONG BALANCE
SHEET,
WITH CASH ON HAND TO FUND OPERATIONS INTO FIRST HALF OF 2025
    * PASSAGE BIO INC- QTRLY LOSS PER SHARE $0.63

Source text for Eikon:  ID:nGNX8wNdsL 
Further company coverage:  PASG.O 

 ((Reuters.Briefs@thomsonreuters.com;))